Literature DB >> 14688331

Effects of T cell frequency and graft size on transplant outcome in mice.

Chunshui He1, Soren Schenk, Qiwei Zhang, Anna Valujskikh, Jörg Bayer, Robert L Fairchild, Peter S Heeger.   

Abstract

The features that determine whether graft-reactive T lymphocytes develop into effector cells capable of mediating organ destruction are not well understood. To investigate potential factors involved in this process, we first confirmed that female recipient mice acutely rejected minor Ag-disparate male skin, but not heart transplants. Despite this difference in outcome, heart and skin transplantation induced antidonor T cell responses of similar magnitude, specificity, and cytokine profile. The heart-graft-primed T cells transiently infiltrated the graft and ultimately induced the development of chronic transplant vasculopathy. Increasing the frequency of donor-reactive T cells by presensitization or by using TCR (CD8+ antimale)-transgenic recipients did not mediate acute rejection but accelerated the pace and severity of the vasculopathy. Surprisingly, decreasing the tissue mass of the donor heart by 50% resulted in acute rejection of these smaller grafts without increasing the frequency of antidonor effector T cells in the recipients. In complementary studies, placement of one or two male skin grafts on a single recipient did not affect the frequency or cytokine profile of the induced antimale T cell repertoire. Nonetheless, the recipients of single grafts acutely rejected the transplanted skin while the recipients of two skin grafts did not. These results provide new insight into the pathogenesis of transplant vasculopathy and provide an explanation for the difference in outcome between murine skin and heart transplants by highlighting the novel concept that the efficiency of transplant-reactive T cell immunity is heavily influenced by the tissue burden it encounters at the effector stage.

Entities:  

Mesh:

Year:  2004        PMID: 14688331     DOI: 10.4049/jimmunol.172.1.240

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Transplant tolerance: models, concepts and facts.

Authors:  Nicola J Monk; Roseanna E G Hargreaves; Elizabeth Simpson; Julian P Dyson; Stipo Jurcevic
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

2.  Langerhans cells are not required for efficient skin graft rejection.

Authors:  Jagdeep S Obhrai; Martin Oberbarnscheidt; Na Zhang; Daniel L Mueller; Warren D Shlomchik; Fadi G Lakkis; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

Review 3.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

4.  Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.

Authors:  Vasile Pavlov; Hugo Raedler; Shuguang Yuan; Staci Leisman; Wing-Hong Kwan; Peter N Lalli; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 5.  T-cell exhaustion in allograft rejection and tolerance.

Authors:  Edward B Thorp; Christian Stehlik; M Javeed Ansari
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

6.  Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies.

Authors:  Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 7.  Memory T cells and their exhaustive differentiation in allograft tolerance and rejection.

Authors:  Anna Valujskikh; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2012-02       Impact factor: 2.640

8.  Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study.

Authors:  Jamie L Todd; Megan L Neely; Heather Kopetskie; Michelle L Sever; Jerry Kirchner; Courtney W Frankel; Laurie D Snyder; Elizabeth N Pavlisko; Tereza Martinu; Wayne Tsuang; Michael Y Shino; Nikki Williams; Mark A Robien; Lianne G Singer; Marie Budev; Pali D Shah; John M Reynolds; Scott M Palmer; John A Belperio; S Sam Weigt
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

9.  Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts.

Authors:  Paul S Russell; Catharine M Chase; Joren C Madsen; Tsutomu Hirohashi; Lynn D Cornell; Thomas J Sproule; Robert B Colvin; Derry C Roopenian
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

10.  Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues.

Authors:  Cavit D Kant; Yoshinobu Akiyama; Katsunori Tanaka; Susan Shea; Yohei Yamada; Sarah E Connolly; Jose Marino; Georges Tocco; Gilles Benichou
Journal:  J Immunol       Date:  2014-12-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.